CEL-SCI Reports September Patient Enrollment for Its Phase 3 Head and Neck Cancer Trial
October 01, 2015 at 08:32 AM EDT
CEL-SCI Corporation (NYSE MKT: CVM) ("CEL SCI" or the "Company") today announced that in the month of September it has enrolled 30 ...